Continuous hyperfractionated accelerated radiotherapy (CHART) using volumetric modulated arc therapy (VMAT) for locally advanced non-small cell lung cancer (NSCLC) - the clinical experience

被引：1
作者：
Shrimali, R. [1 ]
Sen, P. [1 ]
Arunsingh, M. [1 ]
Mahata, A. [2 ]
Mallick, I. [1 ]
Prasath, S. [2 ]
Achari, R. [1 ]
Chatterjee, S. [1 ]
机构：
[1] Tata Med Ctr, Radiat Oncol, Kolkata, India
[2] Tata Med Ctr, Kolkata, India
来源：
LUNG CANCER | 2016年 / 91卷
关键词：
D O I：
10.1016/S0169-5002(16)30138-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
121
引用
收藏
页码：S43 / S44
页数：2
相关论文
共 50 条
  • [31] Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell lung cancer: Pooled results from 5 UK centres
    Din, O.
    Hatton, M.
    Cameron, A.
    Lester, J.
    Moore, B.
    Erridge, S.
    Ironside, J.
    Warnock, J.
    Gee, A.
    Falk, S.
    Klinsman, J.
    Morgan, S.
    Worvill, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S192 - S192
  • [32] Clinical Outcomes of Chemoradiotherapy Using Volumetric Modulated Arc Therapy (VMAT) for Locally Advanced Esophageal Cancer: A Single Institute Experience
    Famed, M. M.
    Shaikh, P. M., Jr.
    Raza, S. M.
    Abubakar, M.
    Amjad, N.
    Afzal, A.
    Fatima, H.
    Mughal, M.
    Clump, D. A., II
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E442 - E442
  • [33] Comment on: "Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial"
    Cengiz, M
    Selek, U
    Yildiz, F
    Sari, S
    [J]. RADIOTHERAPY AND ONCOLOGY, 2005, 74 (01) : 76 - 77
  • [34] Dosimetric and Clinical Benefits of Conformal Radiotherapy Plus Volumetric Modulated Arc Therapy in the Treatment of Non-small Cell Lung Cancer
    Jin, Xiance
    Xie, Congying
    [J]. WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, 2015, VOLS 1 AND 2, 2015, 51 : 392 - 396
  • [35] Dosimetric and Clinical Benefits of Conformal Radiotherapy Plus Volumetric Modulated Arc Therapy in the Treatment of Non-Small Cell Lung Cancer
    Jin, X.
    Xie, C.
    [J]. MEDICAL PHYSICS, 2015, 42 (06) : 3704 - 3705
  • [36] The therapy of locally advanced non-small cell lung cancer (NSCLC) in the elderly
    Schild, S. E.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S7 - S7
  • [37] Hyperfractionated accelerated radiotherapy with doze escalation in non-small cell lung cancer
    Zolotkov, Alexey G.
    Mardynsky, Yury S.
    Ragulin, Yury A.
    Medvedev, Victor N.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S954 - S955
  • [38] INDUCTION CHEMOTHERAPY AND CONTINUOUS HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (CHART) FOR PATIENTS WITH LOCALLY ADVANCED INOPERABLE NON SMALL-CELL LUNG CANCER: THE MRC INCH RANDOMIZED TRIAL
    Hatton, Matthew
    Nankivell, Matthew
    Lyn, Ethan
    Falk, Stephen
    Pugh, Cheryl
    Navani, Neal
    Stephens, Richard
    Parmar, Mahesh
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (03): : 712 - 718
  • [39] Original association of chemo and radiotherapy for locally advanced non-small cell lung cancer (NSCLC): LIEGE experience
    Bosquee, L
    Bustin, F
    Gustin, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 698S - 698S
  • [40] Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
    Saunders, M
    Dische, S
    Barrett, A
    Harvey, A
    Griffiths, G
    Parmar, M
    [J]. RADIOTHERAPY AND ONCOLOGY, 1999, 52 (02) : 137 - 148
12345